CLINICAL_TRIALS
trial_result
· 2012-10-11
Clinical Trial Update: Optimal Dosing of Omeprazole in Neonates [Phase 2]
Summary
A Phase 2 trial evaluating the optimal dosing of omeprazole in neonates with gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 2 | Status: COMPLETED